Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma Patients (N = 119) with ≥one ...
Application of a Data Quality Framework to Ductal Carcinoma In Situ Using Electronic Health Record Data From the All of Us Research Program The availability and timing of clinician assessments was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results